Arcutis Biotherapeutics, Inc. ARQT Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s retained earnings?
- Arcutis Biotherapeutics, Inc. (ARQT) reported retained earnings of -$1.15B in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s retained earnings changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s retained earnings decreased by 0.2% year-over-year, from -$1.15B to -$1.15B.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s retained earnings has grown at a 41.3% compound annual growth rate (CAGR), from -$201.95M to -$1.14B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.